711 related articles for article (PubMed ID: 18804518)
1. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
2. Thalamic changes in Parkinson's disease.
Halliday GM
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S152-5. PubMed ID: 20082979
[TBL] [Abstract][Full Text] [Related]
3. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
[TBL] [Abstract][Full Text] [Related]
7. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
Henderson JM; Carpenter K; Cartwright H; Halliday GM
Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
[TBL] [Abstract][Full Text] [Related]
8. [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C; Hauw JJ
Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
[TBL] [Abstract][Full Text] [Related]
9. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
12. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease.
Xuereb JH; Perry RH; Candy JM; Perry EK; Marshall E; Bonham JR
Brain; 1991 Jun; 114 ( Pt 3)():1363-79. PubMed ID: 2065255
[TBL] [Abstract][Full Text] [Related]
13. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease.
Harding AJ; Stimson E; Henderson JM; Halliday GM
Brain; 2002 Nov; 125(Pt 11):2431-45. PubMed ID: 12390970
[TBL] [Abstract][Full Text] [Related]
15. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
16. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
[TBL] [Abstract][Full Text] [Related]
17. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
18. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Dalfó E; Ferrer I
Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
[TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies and Parkinson's disease.
McKeith IG; Mosimann UP
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S15-8. PubMed ID: 15109582
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord lesions in sporadic Parkinson's disease.
Del Tredici K; Braak H
Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
